The launch episode of Pulse, Infiligence's podcast series in collaboration with Control Alt. Host Vida speaks with Infiligence CEO Ram Sathia.
What is discussed?
- Why life sciences is the one industry where you cannot A/B test human life, and how governance can be built into the workflow rather than bolted on at the end?
- The Moderna case study: mRNA as a "digital biotech" platform and how a virus sequence became a trial candidate in roughly 66 days. Ram's path from T-Mobile, American Express, and Nike to life sciences, and what "automating the automation" means.
- Why security, scalability, and compliance are the three levers of every transformation, and how technical debt drains AI budgets?
- Three ways to apply AI: assisted productivity, collaboration, or full workflow redesign, and why RPA was a band-aid.
- Frontier vs. open models, ontologies, and model routing. Forward-deployed engineering, "tenacity," and Infiligence's Canada center of excellence.
- Episodic data and the interoperability problem across trial, data capture, and adverse reporting systems.
